These allow the conclusion that more than 25% of glioblastoma tumors express elevated levels of either one or both of PCFT and FOLR1, respectively, and more than 50% of low grade gliomas overexpress FOLR1. The gene discussed is FOLR1; the disease is central nervous system cancer.